Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Pacific Biosciences (PACB)
Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,118,640
  • Shares Outstanding, K 249,891
  • Annual Sales, $ 128,300 K
  • Annual Income, $ -314,250 K
  • 60-Month Beta 1.67
  • Price/Sales 23.31
  • Price/Cash Flow N/A
  • Price/Book 4.32
Trade PACB with:

Options Overview Details

View History
  • Implied Volatility 61.94% ( -1.24%)
  • Historical Volatility 45.90%
  • IV Percentile 1%
  • IV Rank 8.59%
  • IV High 379.80% on 07/08/22
  • IV Low 32.06% on 07/01/22
  • Put/Call Vol Ratio 0.16
  • Today's Volume 429
  • Volume Avg (30-Day) 1,539
  • Put/Call OI Ratio 0.48
  • Today's Open Interest 64,454
  • Open Int (30-Day) 64,220

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate -0.34
  • Number of Estimates 4
  • High Estimate -0.32
  • Low Estimate -0.36
  • Prior Year -0.34
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.85 +26.70%
on 04/28/23
13.43 -7.07%
on 05/22/23
+2.51 (+25.18%)
since 04/26/23
3-Month
8.01 +55.81%
on 03/10/23
13.43 -7.07%
on 05/22/23
+3.71 (+42.30%)
since 02/24/23
52-Week
3.85 +224.16%
on 06/14/22
14.20 -12.11%
on 08/11/22
+7.07 (+130.68%)
since 05/26/22

Most Recent Stories

More News
PacBio to Present at Upcoming Investor Conferences

/PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that it will be participating...

PACB : 12.48 (+4.26%)
PacBio to Present at BofA Securities 2023 Health Care Conference

/PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that it will be participating...

PACB : 12.48 (+4.26%)
PacBio (PACB) Tops on Q1 Earnings, Raises FY23 Revenue View

PacBio (PACB) witnesses strong revenue growth in the first quarter. This is partly aided by customers' product transition to the Revio system.

ISRG : 306.90 (+1.03%)
EW : 82.01 (+0.44%)
MMSI : 81.44 (+0.61%)
PACB : 12.48 (+4.26%)
Pacific Biosciences of California (PACB) Reports Q1 Loss, Tops Revenue Estimates

Pacific Biosciences (PACB) delivered earnings and revenue surprises of 6.06% and 10.55%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

PACB : 12.48 (+4.26%)
DYNT : 0.8567 (+2.35%)
Pacific Biosciences: Q1 Earnings Snapshot

Pacific Biosciences: Q1 Earnings Snapshot

PACB : 12.48 (+4.26%)
PacBio Announces Record Revenue in First Quarter 2023

/PRNewswire/ -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2023. First quarter results Revenue of $38.9 million, a...

PACB : 12.48 (+4.26%)
All You Need to Know About Pacific Biosciences (PACB) Rating Upgrade to Buy

Pacific Biosciences (PACB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

PACB : 12.48 (+4.26%)
PacBio's (PACB) New Offering to Enable High-Throughput Workflows

PacBio's (PACB) latest launch is expected to combine the power of HiFi sequencing and Nanobind technology to optimize sample preparation workflows for its high-volume customers.

HOLX : 79.03 (+0.66%)
HSIC : 74.92 (-0.21%)
MASI : 157.35 (-0.39%)
PACB : 12.48 (+4.26%)
RIP to These 3 Dying Medical Stocks

Since the high inflation is leading to rising healthcare spending, it could be wise to sell fundamentally weak medical stocks, Pacific Biosciences (PACB), DermTech (DMTK), and Genetic Technologies (GENE),...

DMTK : 2.47 (+0.41%)
GENE : 0.9640 (-2.63%)
PACB : 12.48 (+4.26%)
PacBio Announces New Nanobind Extraction Kits to Enable High-Throughput Workflows with Revio and Sequel Systems

/PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the availability of its new...

PACB : 12.48 (+4.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time...

See More

Key Turning Points

3rd Resistance Point 13.76
2nd Resistance Point 13.33
1st Resistance Point 12.90
Last Price 12.48
1st Support Level 12.04
2nd Support Level 11.61
3rd Support Level 11.18

See More

52-Week High 14.20
Last Price 12.48
Fibonacci 61.8% 10.25
Fibonacci 50% 9.02
Fibonacci 38.2% 7.80
52-Week Low 3.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar